Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 5 Lymphatic Metastasis 4 Uterine Cervical Neoplasms 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Lung Neoplasms 2 Carcinoma, Transitional Cell 2 Urologic Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Radiation Injuries 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Mixed Tumor, Mesodermal 1 Esophageal Neoplasms 1 Disease 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Adenocarcinoma of Lung 1

Interventions

Radiotherapy 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Cyclophosphamide 7 Busulfan 7 Whole-Body Irradiation 6 Melphalan 6 Radiofrequency Ablation 5 Mycophenolic Acid 5 Filgrastim 5 Antilymphocyte Serum 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Methotrexate 4 Etoposide 4 Drug Therapy 4 Cisplatin 4 fludarabine 3 Radiosurgery 3 Injections 3 Hepatectomy 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 lenvatinib 2 Vinblastine 2 Videotape Recording 2 Thiotepa 2 Standard of Care 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Lymph Node Excision × Clear all

NCT03230201 2017-08-08

UTUC

Peking University First Hospital

Phase NA Unknown

Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡